Although the evidence collected in prostate, lung cancers and cholangiocarcinoma attested a close association between activated COX-2/PGE2 and JAK2/STAT3 signaling pathways [13–15], such correlation and its importance in CRC still need to be elucidated. This evidence concerns the gene STAT3 and cholangiocarcinoma.